Millions of Brits will be offered a Pfizer vaccine booster later this year, even if their first two doses were from another provider, because it has proved to be more effective against the Delta Covid variant.
Ministers will announce today that only vulnerable children will be given Covid vaccines at first, but reports have already emerged that all children – vulnerable or not – could be called up by the end of the year.
America's medicines regulator will decide on whether to fully approve the use of the Pfizer Covid Vaccine – currently only granted emergency use authorisation – in the U.S. for those aged 16 and over by January 2022.
As infections resurge in Israel, the Government reports that the effectiveness of the Pfizer vaccine has dropped to 64% from 94% before. However, the effectiveness against serious disease is holding up.
The U.S. medicines regulator is set to add a warning to the Pfizer and Moderna Covid vaccines after the CDC said there is a "likely link" between them and cases of heart inflammation.
The U.S. Centers for Disease Control will hold an emergency meeting over 226 cases of heart inflammation in young Americans who have received two doses of either the Pfizer or Moderna Covid vaccine.
The U.K. has moved a step closer to vaccinating its children against Covid today, with the medicines regulator having approved the use of the Pfizer vaccine in those aged 12-15.
New data from PHE suggests the vaccines are 90% effective in preventing symptomatic infection in the over 65s. But the study has numerous problems. It also shows the post-vaccine infection spike again.
The vaccine rollout is set to extend to those below the age of 40 from Thursday, with the Pfizer and Moderna vaccines being offered as alternatives to that made by AstraZeneca "where possible".
Two new vaccines studies from PHE bring encouraging news on protection against hospitalisation and death. But they leave me with more questions than answers.
